Naproxen/Esomeprazole Rowex (Esomeprazole, Naproxen)

Naproxen/Esomeprazole, the active ingredient in Naproxen/Esomeprazole Rowex, is a NSAID/Proton pump inhibitor presented as a combined oral tablet for oral use. It provides analgesic and anti‑inflammatory effects while protecting the stomach in adults with musculoskeletal pain and inflammatory joint conditions.

GNH USA supplies Naproxen/Esomeprazole Rowex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across EU and global markets.

Naproxen/Esomeprazole is indicated for conditions where pain, inflammation, and gastric protection are required.

- Osteoarthritis: reduces joint pain and swelling while lowering risk of NSAID‑related gastric ulcers. - Rheumatoid arthritis: alleviates inflammatory symptoms and provides gastro‑protective effect during chronic NSAID therapy. - Acute musculoskeletal pain: offers rapid analgesia and anti‑inflammatory action with concurrent ulcer prevention. - Gastro‑oesophageal reflux disease (GERD) requiring NSAID therapy: controls acid secretion and protects the gastric mucosa.

Naproxen/Esomeprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dyspepsia: upper abdominal discomfort or fullness. - Headache: mild to moderate intensity. - Nausea: feeling of sickness, sometimes with vomiting. - Diarrhea: loose stools. - Constipation: reduced bowel movements. - Abdominal pain: cramping or tenderness.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. - Liver enzyme elevation indicating possible hepatic injury. - Acute renal failure or significant decline in kidney function. - Thrombotic events such as myocardial infarction or stroke (especially with high NSAID exposure). - Severe electrolyte disturbances (e.g., hypomagnesemia).

Before prescribing Naproxen/Esomeprazole, clinicians should consider several precautionary measures to ensure patient safety.

- Assess gastrointestinal risk: evaluate history of ulcers, bleeding, or chronic NSAID use. - Monitor renal function: check serum creatinine and electrolytes, especially in elderly or dehydrated patients. - Evaluate cardiovascular status: avoid in patients with recent myocardial infarction or uncontrolled hypertension. - Use lowest effective dose: limit duration to the shortest period needed for symptom control. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Naproxen/Esomeprazole can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Other NSAIDs (e.g., ibuprofen, diclofenac): increase risk of gastrointestinal bleeding. - Anticoagulants (e.g., warfarin, direct oral anticoagulants): potentiate bleeding tendency. - Selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline): elevate bleeding risk. - Corticosteroids (e.g., prednisone): synergistic ulcerogenic effect. - CYP2C19 inhibitors (e.g., omeprazole, fluconazole): may raise esomeprazole plasma levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs (e.g., lisinopril, losartan): may reduce renal perfusion when combined with NSAIDs. - Diuretics (e.g., furosemide): risk of reduced diuretic efficacy and renal impairment. - Lithium: NSAIDs can increase lithium concentrations. - Methotrexate: NSAIDs may decrease clearance, raising toxicity risk. - Antihypertensives (e.g., beta‑blockers): monitor blood pressure as NSAIDs may blunt antihypertensive effect.